Science

Lilly antibody drug fails in a COVID-19 study; others go on

FILE – In this May 2020 file photo provided by Eli Lilly, a researcher tests possible COVID-19 antibodies in a laboratory in Indianapolis. On Monday, Oct. 26, 2020, U.S. government officials announced they are putting an early end to a study testing an Eli Lilly antibody drug for people hospitalized with COVID-19 because it doesn’t seem to help. (David Morrison/Eli Lilly via AP, File) NYSB101 NYSB101

U.S. government officials are putting an early end to a study testing an Eli Lilly antibody drug for people hospitalized with COVID-19 because it doesn’t seem to be helping them. It is a setback for one of the most promising treatment approaches.

More Headlines